Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine-PCI
NCT02594111Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- May 2013
- Primary completion
- Aug 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in coronary artery disease (CAD), acute coronary syndrome (ACS), sponsored by VA Office of Research & Development. Started May 2013; status: completed.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02594111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594111.